CIMYM BioSciences (Nimotuzumab Assets) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
CIMYM BioSciences (Nimotuzumab Assets) General Information
Description
A drug asset.
Contact Information
Corporate Office
- London
- England, United Kingdom
Corporate Office
- London
- England, United Kingdom
CIMYM BioSciences (Nimotuzumab Assets) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CIMYM BioSciences (Nimotuzumab Assets) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CIMYM BioSciences (Nimotuzumab Assets) FAQs
-
Where is CIMYM BioSciences (Nimotuzumab Assets) headquartered?
CIMYM BioSciences (Nimotuzumab Assets) is headquartered in London, United Kingdom.
-
What industry is CIMYM BioSciences (Nimotuzumab Assets) in?
CIMYM BioSciences (Nimotuzumab Assets)’s primary industry is Buildings and Property.
-
Is CIMYM BioSciences (Nimotuzumab Assets) a private or public company?
CIMYM BioSciences (Nimotuzumab Assets) is a Private company.
-
What is CIMYM BioSciences (Nimotuzumab Assets)’s current revenue?
The current revenue for CIMYM BioSciences (Nimotuzumab Assets) is .
-
Who are CIMYM BioSciences (Nimotuzumab Assets)’s investors?
CIMYM BioSciences has invested in CIMYM BioSciences (Nimotuzumab Assets).
-
When was CIMYM BioSciences (Nimotuzumab Assets) acquired?
CIMYM BioSciences (Nimotuzumab Assets) was acquired on 03-Dec-2012.
-
Who acquired CIMYM BioSciences (Nimotuzumab Assets)?
CIMYM BioSciences (Nimotuzumab Assets) was acquired by Innokeys.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process